Scarica l'app Stockscreener
1.94
2.42%
0.04
Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie
Treace Medical Concepts to Release Q4 and Full Year 2025 Financial Results - Intellectia AI
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - Bitget
Treace Medical Concepts to Release Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 - Quiver Quantitative
Why is Treace Medical Concepts Inc stock going up2025 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update - Finviz
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Upgraded at Wall Street Zen - MarketBeat
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Institutional owners may consider drastic measures as Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) recent US$29m drop adds to long-term losses - simplywall.st
301,100 Shares in Treace Medical Concepts, Inc. $TMCI Acquired by Acuitas Investments LLC - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring A Potential 81% Upside - DirectorsTalk Interviews
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts sees revenue fall in the fourth quarter - Jacksonville Daily Record
How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts Reports Q3 2025 Financial Results - MSN
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Critical Analysis: Treace Medical Concepts (NASDAQ:TMCI) versus Adagio Medical (NASDAQ:ADGM) - Defense World
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside - DirectorsTalk Interviews
Downgrade Watch: Will Treace Medical Concepts Inc stock hit new highs in YEARJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Treace Medical Concepts’ preliminary revenue down 9% in Q4 2025 - Medical Buyer
Treace Medical Issues Preliminary Q4 Results, Highlights Growth - TipRanks
Treace Medical Concepts, Inc. Provides Preliminary Revenue for the Fourth Quarter of 2025 - marketscreener.com
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - The Manila Times
Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative
Published on: 2026-01-13 05:27:40 - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
How Treace Medical Concepts Inc. stock compares to industry benchmarksAnalyst Downgrade & Advanced Technical Analysis Signals - ulpravda.ru
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - The Manila Times
Will Treace Medical Concepts Inc. stock recover faster than market2025 Valuation Update & Growth Oriented Trade Recommendations - Улправда
Will Treace Medical Concepts Inc. stock return to pre crisis levels2025 Pullback Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Treace Medical Concepts Inc. stock outperform Nasdaq indexDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Dow Theory LettersTreace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - FinancialContent
Is Treace Medical Concepts Inc. stock oversold or undervaluedMarket Activity Report & Accurate Intraday Trade Tips - Улправда
How Treace Medical Concepts Inc. stock reacts to Fed rate cutsJuly 2025 Spike Watch & Precise Buy Zone Identification - Улправда
How Treace Medical Concepts Inc. stock benefits from tech adoptionJuly 2025 Update & Breakout Confirmation Alerts - Улправда
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts - Benzinga
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st
How Recent Guidance Shifts Are Rewriting The Story For Treace Medical Concepts (TMCI) - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during Fed tightening cycles2026 world cup usa national team round of 16 goalkeepers transition play odds analysis tactical review - Улправда
Treace Medical’s Earnings Call: Growth Amid Challenges - MSN
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 115% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Bunion-focused medtech CEO to speak at J.P. Morgan Healthcare Conference - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading Down 0.8%Time to Sell? - MarketBeat
1.49%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):